Biblio

Found 12 results
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Wiendl, H  [Clear All Filters]
2011
Klotz L, Gold R, Hemmer B, Korn T, Zipp F, Hohlfeld R, Kieseier BC, Wiendl H. [Diagnosis of multiple sclerosis 2010 revision of the McDonald criteria]. Nervenarzt [Internet]. 2011;82:1302-1309. Available from: http://www.hubmed.org/display.cgi?uids=21681517
Waschbisch A, Sandbrink R, Hartung HP, Kappos L, Schwab S, Pohl C, Wiendl H. Evaluation of soluble HLA-G as a biomarker for multiple sclerosis. Neurology [Internet]. 2011;77:596-598. Available from: http://www.hubmed.org/display.cgi?uids=21795647
Joseph J, Bittner S, Kaiser FM, Wiendl H, Kissler S. IL-17 Silencing Does Not Protect Nonobese Diabetic Mice from Autoimmune Diabetes. J Immunol [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=22116823
Ehling P, Bittner S, Budde T, Wiendl H, Meuth SG. Ion channels in autoimmune neurodegeneration. FEBS Lett [Internet]. 2011;585:3836-3842. Available from: http://www.hubmed.org/display.cgi?uids=21501610
Metz I, Radue EW, Oterino A, Kümpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V, et al. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathol [Internet]. 2011. Available from: http://www.hubmed.org/display.cgi?uids=22057786
Bittner S, Höhn K, Göbel K, Kleinschnitz C, Wiendl H, Meuth SG. [Pregabalin and gabapentin in multiple sclerosis: clinical experiences and therapeutic implications]. Nervenarzt [Internet]. 2011;82:1273-1280. Available from: http://www.hubmed.org/display.cgi?uids=21647743
Kieseier BC, Wiendl H, Hartung HP, Leussink VI, Stüve O. Risks and benefits of multiple sclerosis therapies: need for continual assessment?. Curr Opin Neurol [Internet]. 2011;24:238-243. Available from: http://www.hubmed.org/display.cgi?uids=21483261
2010
Schwab N, Zozulya AL, Kieseier BC, Toyka KV, Wiendl H. An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. J Immunol [Internet]. 2010;184:5368-5374. Available from: http://www.hubmed.org/display.cgi?uids=20357264
Bittner S, Bobak N, Herrmann AM, Göbel K, Meuth P, Höhn KG, Stenner MP, Budde T, Wiendl H, Meuth SG, et al. Upregulation of K(2P)5.1 potassium channels in multiple sclerosis. Ann Neurol [Internet]. 2010;68:58-69. Available from: http://www.hubmed.org/display.cgi?uids=20582984
2008
Melzer N, Meuth SG, Torres-Salazar D, Bittner S, Zozulya AL, Weidenfeller C, Kotsiari A, Stangel M, Fahlke C, Wiendl H, et al. A beta-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis. PLoS ONE [Internet]. 2008;3. Available from: http://www.hubmed.org/display.cgi?uids=18773080
Melzer N, Meuth SG, Torres-Salazar D, Bittner S, Zozulya AL, Weidenfeller C, Kotsiari A, Stangel M, Fahlke C, Wiendl H, et al. A beta-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis. PLoS ONE [Internet]. 2008;3. Available from: http://www.hubmed.org/display.cgi?uids=18773080
2007
Airas L, Nikula T, Huang YH, Lahesmaa R, Wiendl H. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. J Neuroimmunol [Internet]. 2007;187:205-211. Available from: http://www.hubmed.org/display.cgi?uids=17561269